Commentary | Published:

The changing economics of DNA synthesis

Nature Biotechnology volume 27, pages 10911094 (2009) | Download Citation

Subjects

How are the economics of synthetic biology likely to develop in the coming years?

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Science 319, 1215–1220 (2008).

  2. 2.

    & Nucleic Acids Res. 37, e16 (2009).

  3. 3.

    SynBuild, an accurate high-throughput gene assembly platform that uses microarray synthesized oligos. Poster at Synthetic Biology 4.0, Hong Kong, China, October 10–12, 2008.

  4. 4.

    Nucleic Acids Res. published online, 10.1093/nar/gkp687 (10 September 2009).

  5. 5.

    Synthetic biology in pursuit of low-cost, effective, anti-malarial drugs. Presentation at the Institute for Systems Biology Seventh Annual International Symposium, Seattle, April 21, 2008.

  6. 6.

    Nat. Biotechnol. 27, 984 (2009).

  7. 7.

    Syst. Synth. Biol. 1, 109–117 (2007).

  8. 8.

    Biology is Technology (Harvard University Press, Cambridge, in the press).

  9. 9.

    , & Genome Synthesis and Design Futures: Implications for the US Economy (Bio Economic Research Associates, Cambridge, Massachusetts, 2007).

  10. 10.

    , , & Synthetic Genomics: Options for Governance (J. Craig Venter Institute, The Center for Strategic and International Studies, Massachusetts Institute of Technology, October 2007).

  11. 11.

    Biosecur. Bioterror. 1, 203–214 (2003).

  12. 12.

    Science 203, 614–625 (1979).

  13. 13.

    , , & Gene 94, 103–107 (1990).

  14. 14.

    , , , & Gene 164, 49–53 (1995).

  15. 15.

    , & Science 297, 1016–1018 (2002).

  16. 16.

    et al. Nature 432, 1050–1054 (2004).

  17. 17.

    et al. Proc. Natl. Acad. Sci. USA 101, 15573–15578 (2004).

Download references

Acknowledgements

Portions of this text are drawn from Biology is Technology, scheduled for publication in 2010. I would like to thank J. Mulligan, J. Minshull, J. Koschwanez, L. Stewart, D. Endy and R. Wehbring for illuminating and entertaining discussions.

Author information

Affiliations

  1. Robert Carlson is at Biodesic, Seattle, Washington, USA.

    • Robert Carlson

Authors

  1. Search for Robert Carlson in:

Competing interests

Novici, one of the companies mentioned in this article, is a client of R.C.’s company Biodesic.

Corresponding author

Correspondence to Robert Carlson.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt1209-1091

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing